Jacome Lizbeth Soto, Deshmukh Sachin Kumar, Thulasiraman Padmamalini, Holliday Nicolette Paolaungthong, Singh Seema
Department of Biomedical Sciences, College of Allied Health, University of South Alabama, Mobile, AL 36688, USA.
Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Cancer Manag Res. 2021 Jan 14;13:359-366. doi: 10.2147/CMAR.S287152. eCollection 2021.
COVID-19, also known as the coronavirus disease 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) declared pandemic by the World Health Organization (WHO). As the world faces the coronavirus disease 2019 crisis, the oncology community is being impacted by unprecedented challenges. During this trying time, patients with ovarian cancer (OC) have been affected by a delay in diagnosis, surgery, chemotherapy and radiation treatments, and oncology follow-ups being conducted via telemedicine instead of in-person visits. OC patients and their oncologists are balancing the fears of COVID-19 and cancer treatment with the consequences of delaying cancer care. The delay in treatment care that women with OC are experiencing has resulted in higher levels of cancer worry, anxiety, and depression. In this article, we succinctly review the impact of the COVID-19 pandemic on the diagnosis and treatment and ongoing clinical trials of OC. We also discuss the psychological effects of COVID-19 on women with OC and alternative therapeutic strategies to limit in-person hospital visits to reduce the spread of the disease, and the impact of COVID-19 on OC patients.
2019冠状病毒病（COVID-19），又称新型冠状病毒肺炎，由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起，世界卫生组织（WHO）已宣布其为大流行病。随着全球面临2019冠状病毒病危机，肿瘤学界正受到前所未有的挑战影响。在这个艰难时期，卵巢癌（OC）患者受到诊断、手术、化疗和放疗延迟的影响，肿瘤随访也通过远程医疗而非面对面就诊进行。OC患者及其肿瘤医生正在权衡对COVID-19的恐惧和癌症治疗，以及延迟癌症治疗的后果。OC女性患者所经历的治疗延迟导致了更高程度的癌症担忧、焦虑和抑郁。在本文中，我们简要回顾了COVID-19大流行对OC诊断、治疗及正在进行的临床试验的影响。我们还讨论了COVID-19对OC女性患者的心理影响，以及为限制面对面医院就诊以减少疾病传播而采取的替代治疗策略，以及COVID-19对OC患者的影响。
